ArticleTherapeutic advances in psychopharmacology2020

Safety and efficacy of extended release ketamine tablets in patients with treatment-resistant depression and anxiety: open label pilot study.

Paul Glue et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.